Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

The sentinel node in breast cancer.

Conor D Collins¹

¹St Vincent's University Hospital, Dublin, Ireland. c.collins@st-vincents.ie

Cancer Imaging : the Official Publication of the International Cancer Imaging Society

|October 15, 2008

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trial.

British journal of cancer·2022

Same author

Vascular findings on FDG PET/CT.

The British journal of radiology·2020

Same author

Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.

British journal of cancer·2020

Same author

ICORG 06-35: a prospective evaluation of PET-CT scan in patients with non-operable or non-resectable non-small cell lung cancer treated by radical 3-dimensional conformal radiation therapy: a phase II study.

Irish journal of medical science·2019

Same author

First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma.

American journal of medical genetics. Part A·2019

Same author

High grade follicular lymphoma in a patient receiving adalimumab and methotrexate for pityriasis rubra pilaris.

The Journal of dermatological treatment·2017

Sentinel lymph node biopsy is standard for early breast cancer. This review covers recent advancements and current practices in the procedure.

Area of Science:

Oncology
Surgical Pathology

Background:

Sentinel lymph node biopsy (SLNB) is integral to managing early-stage breast cancer.
Accurate staging is crucial for effective treatment planning.

Purpose of the Study:

To review recent developments in sentinel lymph node biopsy techniques.
To summarize current clinical practice guidelines for SLNB in breast cancer.

Main Methods:

Literature review of advancements in SLNB over recent years.
Synthesis of current evidence and practice recommendations.

Main Results:

SLNB has evolved significantly, improving diagnostic accuracy.
Standardized protocols enhance patient outcomes and reduce morbidity.

More Related Videos

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Related Experiment Videos

Last Updated: Jun 29, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Conclusions:

Sentinel lymph node biopsy remains a cornerstone in early breast cancer management.
Ongoing research continues to refine SLNB techniques and applications.